AKT1 and pancreatic neoplasm: Application of recombinant leptin to pancreatic cancer cells in vitro resulted in a significant increase in the phosphorylation of AKT,in both the murine Panc02 as well as the human Panc1 suggesting that the short form of the receptor was functional in these cells.